Watch as Dr. Michael Elliott, Chief of Neurology at the Swedish Neuroscience Institute, shares his personal experiences and best practices for the diagnosis and management of ALS.
Enroll in the ALS Care Locator
MEDICAL PRACTICE
RADICAVA ORS® recognized as a MAJOR CONTRIBUTION TO PATIENT CARE by the FDA.1 Request a rep visit.
ALS Expert Video Library
Learn more about RADICAVA ORS® (edaravone) for the treatment of ALS through a series of educational videos.
Hear From Your Peers
Experienced neurologists provide their insights for considering RADICAVA ORS® treatment that has been prescribed by 1400+ US HCPs since August 2022.1,a (see footnote)
Providers are paid consultants.
Featured video—Experiences of an ALS Expert, Featuring Dr. Michael Elliott
Experiences of an ALS Expert, Featuring Dr. Michael Elliott
Dosing and administration of RADICAVA ORS® (edaravone)
Learn about the dosing and administration of RADICAVA ORS®, in this video featuring Dr. Michael Elliott.
Dosing and administration of RADICAVA ORS® (edaravone)
Nationwide Webcast Video Discussion About a Treatment in ALS
Stanley H. Appel, MD, and Gary L. Pattee, MD, discuss RADICAVA ORS® data and their thoughts on what oral treatment means to patients.
Nationwide Webcast Video Discussion About a Treatment in ALS
Providers are paid consultants.
See patient and caregiver experiences
with RADICAVA ORS®.
Review educational webinars for ALS patients that may be appropriate for your patients.
Learn more
Add your practice to our ALS Care Locator.
aBased on RADICAVA ORS® prescriptions submitted in the US as of August 2025. Not independently verified. Return to content
References: 1. US Food and Drug Administration. Clinical superiority findings. Accessed April 11, 2024. https://www.fda.gov/industry/designating-orphan-product-drugs-and-biological-products/clinical-superiority-findings 2. Data on file. Jersey City, NJ: Mitsubishi Tanabe Pharma America, Inc.
